about
Silver and gold nanoparticles exposure to in vitro cultured retina--studies on nanoparticle internalization, apoptosis, oxidative stress, glial- and microglial activityAdvanced drug delivery and targeting technologies for the ocular diseasesComprehensive Review of the Literature on Existing Punctal Plugs for the Management of Dry Eye DiseaseThe Human Cathelicidin Antimicrobial Peptide LL-37 and Mimics are Potential Anticancer DrugsThe ocular surface epithelial barrier and other mechanisms of mucosal protection: from allergy to infectious diseasesNanomedicine in the application of uveal melanomaModulation of ocular surface glycocalyx barrier function by a galectin-3 N-terminal deletion mutant and membrane-anchored synthetic glycopolymersSustained Antibiotic-Eluting Intra-Ocular Lenses: A New ApproachUltrasound-enhanced ocular delivery of dexamethasone sodium phosphate: an in vivo study.Development of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability.Therapeutic applications of ultrasound in ophthalmology.RETRACTED: Influence of choroidal neovascularization and biodegradable polymeric particle size on transscleral sustained delivery of triamcinolone acetonide.Influence of drug solubility and lipophilicity on transscleral retinal delivery of six corticosteroidsOne-Year Feasibility Study of Replenish MicroPump for Intravitreal Drug Delivery: A Pilot Study.Tear-mediated delivery of nanoparticles through transcytosis of the lacrimal glandTopical Ocular Drug Delivery to the Back of the Eye by Mucus-Penetrating Particles.Clusterin Seals the Ocular Surface Barrier in Mouse Dry Eye.Immunohistochemical and functional characterization of peptide, organic cation, neutral and basic amino acid, and monocarboxylate drug transporters in human ocular tissues.Intravitreal Corticosteroids in the Management of Diabetic Macular EdemaRecent advances in ocular drug delivery.Antioxidants and cataract.Nanomedicines for back of the eye drug delivery, gene delivery, and imaging.Drug delivery techniques for treating age-related macular degeneration.Inflammation and pharmacological treatment in diabetic retinopathy.A review of topically administered mini-tablets for drug delivery to the anterior segment of the eye.Topical delivery of ocular therapeutics: carrier systems and physical methods.Emerging drugs for diabetic macular edema.A New Vision for the Eye: Unmet Ocular Drug Delivery Needs.Recent developments in ocular drug delivery.Medical management of glaucoma: focus on ophthalmologic drug delivery systems of timolol maleate.Nanocarrier mediated retinal drug delivery: overcoming ocular barriers to treat posterior eye diseases.Drug, delivery and devices for diabetic retinopathy (3Ds in DR).Ultrasound-mediated ocular delivery of therapeutic agents: a review.Minimally invasive microneedles for ocular drug delivery.Diadenosine tetraphosphate induces tight junction disassembly thus increasing corneal epithelial permeability.Development of microemulsions for ocular delivery.Pigmented-MDCK (P-MDCK) cell line with tunable melanin expression: an in vitro model for the outer blood-retinal barrierSoft contact lenses for controlled ocular delivery: 50 years in the making.Hydrophilic prodrug approach for reduced pigment binding and enhanced transscleral retinal delivery of celecoxib.Ciprofloxacin-imprinted hydrogels for drug sustained release in aqueous media.
P2860
Q21131960-B7A831A6-B1BD-49BB-8F4C-3D467AAB11F2Q26747220-DE729ABC-4E6F-4234-849A-EE5C16E09711Q26752848-597BEC29-630D-49F9-86F9-6BD3E4847D49Q26801532-D744B315-3A12-46A2-811E-8B44263D8C92Q26865809-09A5BC2C-5D21-40D2-9603-E098EA19D906Q28079572-BF733943-BE0F-4988-8AC4-3627100BC68DQ28535428-5C33D0D4-5ADF-46C2-88B7-3C739249490AQ28552701-6ADF362B-30E2-4BFC-85BB-413C42EE87C7Q30436895-FF57B2BC-7CAA-45A9-B2A0-D14413595E25Q33558455-1CC6FEB4-F425-4E4B-8047-FF5E2EA96EF5Q34279199-0EAC549E-5DF7-4653-B410-D9CB2154DC1EQ34283230-DD399A36-3AE7-4C94-B8D4-C23EB592B44EQ34856993-13765181-3284-4CE8-A8B3-C0A585C13440Q35167647-36346934-8245-4A82-884D-5ADBD918C5F9Q35684758-F50E7A93-F63E-4CE3-8787-D8DDCABA63F0Q35759073-F4C43027-28D7-4A51-9FF6-87A258EAB35FQ35786703-6A4F360C-2381-42C5-9945-4A7E8855AD89Q36573373-9C47EDB1-CB6F-40F2-94A2-8303219E7031Q37287831-B6D37BCA-E912-4F33-BADF-BCEC566CFDE4Q38059884-88874A6A-3584-4F23-95B8-8C3963FEB1BFQ38084440-D26A01CE-5B4F-4376-86AA-D33948B02DBAQ38100561-A834C218-0F67-4514-A8C5-7BB9FCECC284Q38161953-E93172CA-3EAB-49F8-B9AA-7332AA5B64E0Q38167309-C0BFB5D7-5438-464C-87F2-DF9E842289D6Q38196445-D802ABCD-567A-47D0-844F-12BD97F313C2Q38196446-E19F0768-0DD0-4BD5-9DFE-F28CCC540D15Q38241679-B098235F-2465-4FCC-A42D-03A17ABF471AQ38521315-7792C80B-FA6F-4582-9BA1-7D752D03D8A5Q38603354-D2CC423E-A855-4E12-A5ED-33B159779158Q38784707-B149B247-D183-4D10-AE4A-A11ACF83622AQ38829320-4ED9ADD4-4CD8-4FBE-98E4-440BBED20651Q38832441-993B271D-7C6A-45D9-9955-1D859A35E8BBQ38867140-61CD5D14-5D03-48A5-B8DA-32E4192EDC28Q38916649-26171531-617A-43DC-BD84-8F0D70D383D0Q38949654-721FD9F2-6BEC-4D09-B30C-1B45613A88B0Q39210541-FE4678E6-2634-4A44-9560-86E21078400DQ39273066-B720C5E9-3181-4BE1-B210-3D6368F2449EQ39352210-1914A729-9351-46A3-8367-E16551E58060Q39410312-2BFF04A8-A2CF-4FB8-92E1-3C2F76DAF8FEQ39431679-A55282A7-0D07-4E6A-8592-D300D628BE97
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Recent advances in ophthalmic drug delivery.
@ast
Recent advances in ophthalmic drug delivery.
@en
Recent advances in ophthalmic drug delivery.
@nl
type
label
Recent advances in ophthalmic drug delivery.
@ast
Recent advances in ophthalmic drug delivery.
@en
Recent advances in ophthalmic drug delivery.
@nl
prefLabel
Recent advances in ophthalmic drug delivery.
@ast
Recent advances in ophthalmic drug delivery.
@en
Recent advances in ophthalmic drug delivery.
@nl
P2093
P2860
P356
P1433
P1476
Recent advances in ophthalmic drug delivery.
@en
P2093
Rajendra S Kadam
Uday B Kompella
Vincent H L Lee
P2860
P304
P356
10.4155/TDE.10.40
P577
2010-09-01T00:00:00Z